How Does the Zerona Promote Total Body Wellness?

Kerry’s story is a perfect example!

Kerry lost 6.75 inches in just 6 visits! Best of all, the Zerona helped her lower her total cholesterol, LDL levels (a.k.a. bad cholesterol) and triglyceride levels to within a healthy range! The Zerona promotes not just inch loss, but also increases total health and wellness!

Before Zerona
Total Cholesterol: 282 mg/dL (High)

Triglycerides: 170 mg/Dl (Borderline High)

LDL Cholesterol: 150 mg/dL (Borderline High)

2 weeks, several workouts, healthy eating, and 6 Zerona treatments later…

After Zerona
Total Cholesterol: 247 mg/dL (High, but only 7 units away from borderline!)

Triglycerides: 100 mg/dL (Normal)

LDL Cholesterol: 132 mg/dL (Borderline high, 2 units from being optimal!)

Congratulations to Kerry on achieving a healthy lifestyle with hard work and the Zerona!

Zerona FDA Approved for Inch Loss!

The Zerona Lipo Laser is now the first non-invasive aesthetic device to receive FDA market clearance in the U.S. for circumferential reduction of the waist, hips, and thighs.

The FDA approved the Zerona for inch loss after completing a study evaluating 67 participants. The participants used the laser treatment 3 times per week for 2 weeks and had no diet, exercise, or any other restrictions placed upon them. The result was an average inch loss of 3.65 inches across the patient's waist, hips, and thighs in as little as two weeks.

The Arne Wellness Center has seen this same success with the Zerona laser. With the addition of dieting, supplements, and exercise our patients lose an average of 4-6 inches or more in just 2 weeks! We have also seen the Zerona normalize blood sugar levels and lower elevated blood pressures. These are just a few examples of how the Zerona promotes total body wellness.

The Zerona has been featured on the Rachel Ray show, CBS Early Show, and the Doctors.

You can try the Zerona for free by visiting the Arne Wellness Center. Call (952) 697-3100 or email maggie@arnewellnesscenter.com to set up your free trial!

Visit http://www.arnewellness.com/ to see before/after pictures of our successful patients!

Information for article can be found at http://www.americanhealthandbeauty.com/

We've Won an Award!

Press Release

FOR IMMEDIATE RELEASE

Arne Wellness Center Receives 2010 Best of Minnetonka Award

U.S. Commerce Association’s Award Plaque Honors the Achievement

NEW YORK, NY, September 6, 2010 -- Arne Wellness Center has been selected for the 2010 Best of Minnetonka Award in the Wellness Programs category by the U.S. Commerce Association (USCA).

The USCA "Best of Local Business" Award Program recognizes outstanding local businesses throughout the country. Each year, the USCA identifies companies that they believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and community.

Various sources of information were gathered and analyzed to choose the winners in each category. The 2010 USCA Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the USCA and data provided by third parties.

About U.S. Commerce Association (USCA)
U.S. Commerce Association (USCA) is a New York City based organization funded by local businesses operating in towns, large and small, across America. The purpose of USCA is to promote local business through public relations, marketing and advertising.
The USCA was established to recognize the best of local businesses in their community. Our organization works exclusively with local business owners, trade groups, professional associations, chambers of commerce and other business advertising and marketing groups. Our mission is to be an advocate for small and medium size businesses and business entrepreneurs across America.

SOURCE: U.S. Commerce Association
CONTACT:U.S. Commerce AssociationEmail: PublicRelations@uscaaward.com
URL: http://www.uscaaward.com
###

Zerona Press Release

Pilot Studies Explore Low Level Laser’s Effect on LDL, Leptin, and Parkinson’s Disease

Erchonia Medical presents three new studies at the American Society of Laser Medicine and Surgery Annual Conference in Phoenix, AZ.

Study 1
Erchonia will be presenting a study it conducted using low level lasers to treat late stage Parkinson’s disease. Eight volunteers between 18 and 80 years old with late stage PD participated in the non-controlled, non-randomized study and received low level laser treatments daily for two weeks. Patients were asked to rate the severity of their symptoms (balance, gait, freezing, cognitive function, rolling in bed, and speech difficulties) from 0-10 using the Visual Analog Scale. All participants demonstrated a decrease in VAS from baseline to study endpoint.

Study 2
The second study Erchonia plans to present shows how low-level lasers may reduce low density lipoprotein levels (LDL). Forty one patients between 18 and 65 participated in Erchonia’s non-controlled, non-randomized study. Participants received a 40-minute Zerona laser treatment three times a week for two weeks and demonstrated a reduction in low-density lipoprotein levels of 12.05 points, a 13% reduction. This study suggests that low level laser therapy may serve as a non-invasive way to reduce LDL levels in two weeks.

Study 3
Erchonia’s third study explores how its Zerona laser impacts leptin levels, the hormone linked to hunger. Twenty volunteers between the ages of 18 and 65 participated in Erchonia’s non-controlled, non-randomized study. Participants received 40-minute Zerona low-level laser treatments three times per week for two weeks. All participants demonstrated a reduction in leptin levels compared to their baseline – on average, a 50% decrease. Since leptin levels are associated with hunger, this study shows low level laser technology may noninvasively suppress the appetite.

Ryan Maloney, Erchonia’s medical director and one of the authors of the studies comments, “Although these were non-controlled, non-randomized pilot studies, they each showed promising new applications for low level laser technology. Further study is needed, but Erchonia is paving the way for new noninvasive healthcare technologies with a commitment to research and innovation.”